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Summary This observational, cross-sectional study describes the role
played by clinical microbiology and pharmacy departments in the
stewardship of antibiotic prescribing in European hospitals. A total of 170
acute care hospitals from 32 European countries returned a questionnaire on
antibiotic policies and practices implemented in 2001. Data on antibiotic use,
expressed as Deﬁned Daily Doses per 100 occupied bed-days (DDD/100 BD)
were provided by 139 hospitals from 30 countries. A total of 124 hospitals
provided both datasets. 121 (71%) of Clinical Microbiology departments and
66 (41%) of Pharmacy departments provided out of hours clinical advice.
70 (41%) of microbiology/infectious disease specialists and 28 (16%) of
pharmacists visited wards on a daily basis. The majority of laboratories
provided monitoring of blood cultures more than once per day and summary
data of antibiotic susceptibility testing (AST) for empiric prescribing (86% and
73% respectively). Most of the key laboratory and pharmacy-led initiatives
examined did not vary signiﬁcantly by geographical location. Hospitals
from the North and West of Europe were more likely to examine blood
cultures more than once daily compared with other regions (p < 0.01).
Hospitals in the North were least likely routinely to report susceptibility
results for restricted antibiotics compared to those in the South-East
and Central/Eastern Europe (p < 0.01). Hospital wards in the North were
more likely to hold antibiotic stocks (100%) compared with hospitals
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in the South-East which were least likely (39%) (p < 0.001). Conversely,
hospital pharmacies in the North were least likely to dispense antibiotics
on an individual patient basis (16%) compared with hospital pharmacies
from Southern Europe (60%) (p = 0.01). Hospitals that routinely reported
susceptibility results for restricted antibiotics had signiﬁcantly lower median
total antibiotic use in 2001 (p < 0.01). Hospitals that provided prescribing
advice outside normal working hours had signiﬁcantly higher antibiotic use
compared with institutions that did not provide this service (p = 0.01). A wide
range of antibiotic stewardship measures was practised in the participating
hospitals in 2001, although there remains great scope for expansion of those
overseen by pharmacy departments. Most hospitals had active antibiotic
stewardship programmes led by specialists in infection, although there is no
evidence that these were associated with reduced antibiotic consumption.
There was also no evidence that pharmacy services reduced the amount of
antibiotics prescribed.
© 2007 The Hospital Infection Society. Published by Elsevier Ltd. All rights
reserved.
Introduction
In the battle against the closely related problems of
antibiotic resistance and excessive antibiotic pre-
scribing in the hospital setting, the microbiology
laboratory and pharmacy departments are uniquely
placed to provide information and leadership in
a collaborative atmosphere.1,2 Indeed, there have
been recent calls for the formation of multi-
disciplinary teams3 with pharmacists and infection
specialists providing the backbone to improved
stewardship in European hospitals.4,5
The ARPAC (Antibiotic Resistance: Prevention and
Control) study was established with the aim of
laying the foundations for a better understanding
of the emergence and epidemiology of antibiotic
resistance in human bacterial pathogens. The
project was conducted by four study groups
belonging to the European Society of Clinical
Microbiology and Infectious Diseases (ESCMID).
It collated and analysed data on antimicrobial
susceptibility testing, antimicrobial resistance
prevalence, typing methods, antimicrobial con-
sumption, infection control polices and antibiotic
prescribing policies from European hospitals. The
ESCMID Study Group on Antibiotic Policies (ESGAP)
was responsible for investigating the roles played
by Clinical Microbiology and Pharmacy departments
in the stewardship of antibiotic prescribing in
European hospitals and to establish any association
between such activities and antibiotic use. Its
ﬁndings are presented in this paper.
Materials and methods
Hospital recruitment
This was an observational, cross-sectional study
and was part of a Concerted Action project (ARPAC)
funded by the European Commission (project
number QLK2-CT-2001-00915). This part of the
project was carried out under the auspices of
ESGAP. All full members of ESCMID (approximately
2500) were invited to participate in the ARPAC
study during 2002 and to provide data relating
to 2001; a total of 263 hospitals from European
regions participated in the study.
Data collection
Roles of Clinical Microbiology and Pharmacy
departments
A detailed postal questionnaire was designed to
capture the policies on practices governing antibi-
otic prescribing during 2001. The questionnaire,
to be completed by a medical microbiologist,
infectious-disease physician, ICU physician, phar-
macist or other appropriate person, included
questions on committees, antibiotic availability,
antibiotic policies, audit of antibiotic use, the role
of the laboratory (13 questions) and the role of the
pharmacy (13 questions) in inﬂuencing antibiotic
prescribing. The questionnaire was developed,
piloted and revised by the ARPAC Steering Group
before it was circulated to the 263 recruited
hospitals in 2003.
Antibiotic use data
The European ARPAC participating hospitals were
asked to provide antibiotic use data for J01 an-
tibacterial agents of the World Health Organisation
classiﬁcation, categorised using the Anatomical
Therapeutic Chemical (ATC) classiﬁcation index and
measured using the WHO recommended unit of DDD
per 100 occupied bed-days (DDD/100 BD).6
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Table 1
ARPAC hospitals that provided data on antibiotic prescribing (n = 170)
Northern Europe
n = 19 (11%)
Western Europe
n = 55 (32%)
Centre/East + Baltic States
n = 43 (25%)
South-Eastern Europe
n = 13 (8%)
Southern Europe + Israel
n = 40 (24%)
Denmark (n = 5)
Netherlands (n = 7)
Norway (n = 3)
Sweden (n = 4)
Austria (n = 5)
Belgium (n = 18)
France (n = 6)
Germany (n = 10)
Switzerland (n = 5)
UK (n = 11)
Bulgaria (n = 7)
Czech Republic (n = 3)
Estonia (n = 2)
Hungary (n = 7)
Latvia (n = 2)
Lithuania (n = 3)
Poland (n = 6)
Romania (n = 2)
Russia (n = 1)
Slovakia (n = 5)
Slovenia (n = 5)
Bosnia (n = 2)
Croatia (n = 6)
Macedonia (n = 1)
Yugoslavia (n = 4)
Greece (n = 7)
Israel(n = 2)
Italy (n = 9)
Malta (n = 1)
Portugal (n = 2)
Spain (n = 9)
Turkey (n = 10)
Statistical analysis
Data were analysed by European region using a
modiﬁed version of a standard European reference
system7 with hospitals from the UK categorised
as part of Western rather than Northern Europe
(Table 1).
Data were entered into Microsoft Access 2000,
and an independent validation check was made on
a 10% sample of data entered. Statistical analysis
was conducted using SPSS for Windows (version
12.0). Associations between key stewardship vari-
ables with geographic/hospital factors8 and total
antibiotic use (J01) were analysed using the Chi-
squared test for categorical variables and the
Mann Whitney U test for antibiotic use. P-values
of less than 0.01 were considered statistically
signiﬁcant.
Results
Sample characteristics
A total of 263 hospitals from Europe and Israel
expressed an interest in participating in the
study. Hospitals from Israel were eligible for
inclusion because of a bilateral scientiﬁc co-
operation agreement for EC-funded studies. Of
these, 204 hospitals subsequently submitted at
least one further dataset and are described
elsewhere.8 Completed questionnaires on antibi-
otic prescribing were received from 170 (65%) of
263 ARPAC hospitals across 32 European countries
(Table 1). Comparisons were made between these
170 hospitals and the 93 recruited ARPAC hospitals
that failed to provide antibiotic prescribing data.
Responding hospitals were more likely to have
teaching status (p = 0.05), but there were no
differences by geographical region (p = 0.54),
hospital size (p = 0.64), presence or size of ICU
(p = 0.27). Of the 170 hospitals that provided
antibiotic prescribing data, 130 (76%) had teaching
status, 159 (94%) had an ICU and the median
hospital size was 669 beds (IQR 408, 1022).
Antibiotic consumption data were provided by
139 hospitals from 30 countries and are described
elsewhere.6 124 hospitals provided both antibiotic
prescribing and antibiotic use data.
Microbiology laboratory service
Hospital microbiology laboratory practice is pre-
sented in Table 2. There did appear to be
some variation in practice across geographical
regions. Evidence of variation in the frequency of
examination of blood cultures was found (p < 0.01),
with more hospitals in the North and West of
Europe examining blood cultures more than once
per day compared to other regions. Fewer hospitals
in the North routinely reported susceptibility
results for restricted antibiotics than those in the
South-East and Central/Eastern Europe.
The majority of hospitals provided an emer-
gency microbiology laboratory service (75%) and
prescribing advice (71%) outside normal working
hours (Table 2). The majority also examined
blood cultures more than once a day (86%),
provided antibiotic susceptibility test (AST) data to
physicians to assist with empiric therapy (73%) and
reported AST results for non-formulary antibiotics
when organisms were resistant to formulary
agents (67%). Only 52% routinely reported AST
results for restricted antibiotics. Less than half
(41%) of the clinical microbiologists/ID specialists
conducted daily ward rounds to advise on therapy.
A total of 124 (73%) of hospitals provided sum-
mary antibiotic susceptibility data to guide empiric
therapy. This was sent to individual physicians in
54 (32%), individual units in 64 (38%) and to the
whole hospital in 59 (35%) hospitals. No evidence
of variation by geographical region, hospital size
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Table 2
Hospital microbiology laboratory practice by European region (n = 170 hospitals)
All regions
n = 170 (%)
Missing
(%)
North
n = 19
(%)
West
n = 55
(%)
CE
n = 43
(%)
SE
n = 13
(%)
South
n = 40
(%)
p value*
Hospital laboratory provided an emergency
service outside routine working hours
127 (75) 3 (2) 15 (79) 47 (85) 30 (70) 8 (62) 27 (68) 0.16
Laboratory examined blood cultures
>1 daily
147 (86) 3 (2) 19 (100) 54 (98) 34 (79) 10 (77) 30 (75) <0.01
Microbiology department provided
antibiotic sensitivity test data to
physicians to assist with empiric treatment
124 (73) 5 (3) 11 (58) 37 (67) 33 (78) 11 (85) 32 (80) 0.16
Susceptibility results routinely reported
for restricted antibiotics
88 (52) 15 (9) 3 (16) 25 (45) 31 (72) 9 (69) 20 (50) <0.01
Susceptibility results reported for
non-formulary antibiotics when organisms
resistant to formulary agents
114 (67) 13 (8) 15 (79) 31 (56) 31 (72) 8 (62) 29 (73) 0.02
Prescribing advice was available out with
normal working hours
121 (71) 4 (2) 18 (95) 43 (78) 27 (63) 9 (60) 24 (60) 0.05
Clinical microbiologist/ID specialist
conducted daily ward round to advise on
therapy
70 (41) 7 (4) 11 (58) 27 (49) 13 (30) 4 (31) 15 (38) 0.13
a *Chi-squared test.
Table 3
Hospital pharmacy practice by European region (n = 170)
All regions
n = 170 (%)
Missing
(%)
North
n = 19
(%)
West
n = 55
(%)
CE
n = 43
(%)
SE
n = 13
(%)
South
n = 40
(%)
p
value*
Prescribing advice available from
pharmacist during normal working hours
138 (81) 7 (4) 17 (90) 52 (95) 28 (65) 9 (69) 32 (80) 0.05
Prescribing advice available outside of
working hours, including weekends
66 (41) 10 (6) 9 (47) 30 (55) 12 (28) 2 (15) 13 (33) 0.03
Daily ward visits by pharmacist to advise on
therapy
28 (16) 6 (4) 1 (5) 12 (22) 7 (10) 1 (8) 7 (18) 0.55
Antibiotics dispensed directly from
pharmacy per patient
66 (41) 8 (5) 3 (16) 20 (36) 14 (33) 5 (38) 24 (60) 0.01
Wards held stocks of antibiotics 119 (70) 9 (5) 19 (100) 46 (84) 27 (63) 5 (39) 22 (55) <0.001
*Chi-squared test.
or teaching status was found (data not shown).
Summaries of susceptibility data were fedback
to users at varying intervals: 86 (51%) fedback
annually, 37 (22%) twice or more per year and
13 (8%) less than once yearly. 34 (20%) of hospitals
failed to provide information on the frequency of
feedback of summary susceptibility data.
Only 89 (52%) of laboratories routinely reported
MIC values and only 20 (12%) of hospitals detailed
cost information within the laboratory report.
Role of the pharmacy
Some variation in key pharmacy initiatives across
geographical region was found (Table 3). Variation
in holding antibiotic stocks on the ward ranged
from 100% of hospitals in the North to only
39% of hospitals in the South-East. Conversely, only
16% of hospital pharmacies in the North dispensed
antibiotics on an individual patient basis compared
with 60% of hospital pharmacies in the South.
Overall, the majority of hospital pharmacies
offered prescribing advice during normal working
hours (81%) and held antibiotic stocks at ward
level (70%) (Table 3). 41% offered prescribing
advice outside normal working hours and 41% of
pharmacy departments dispensed antibiotics on an
individual patient basis (Table 3). Most notably,
only 16% of hospitals operated a system whereby
Role of microbiology and pharmacy departments in antibiotic prescribing in European hospitals 77
Ta
bl
e
4
To
ta
l
an
ti
bi
ot
ic
us
e
in
20
01
by
ke
y
la
bo
ra
to
ry
pr
ac
ti
ce
va
ri
ab
le
s
(n
=
12
4)
M
ed
ia
n
an
ti
bi
ot
ic
us
e
(I
Q
R)
D
D
D
/1
00
BD
p
va
lu
e*
H
os
pi
ta
l
la
bo
ra
to
ry
pr
ov
id
ed
an
em
er
ge
nc
y
se
rv
ic
e
ou
ts
id
e
ro
ut
in
e
w
or
ki
ng
ho
ur
s
Ye
s
n
=
98
56
.8
(4
0.
3,
72
.3
)
N
o
n
=
24
47
.4
(3
8.
2,
66
.7
)
0.
19
M
is
si
ng
n
=
2
La
bo
ra
to
ry
ex
am
in
ed
bl
oo
d
cu
lt
ur
es
>1
da
ily
Ye
s
n
=
11
1
55
.4
(4
0.
9,
71
.1
)
N
o
n
=
11
47
.5
(2
4.
9,
81
.4
)
0.
63
M
is
si
ng
n
=
2
M
ic
ro
bi
ol
og
y
de
pa
rt
m
en
t
pr
ov
id
ed
AS
T
da
ta
to
ph
ys
ic
ia
ns
to
as
si
st
w
it
h
em
pi
ri
c
tr
ea
tm
en
t
Ye
s
n
=
88
54
.2
(3
8.
9,
70
.5
)
N
o
n
=
33
59
.3
(4
1.
9,
80
.2
)
0.
41
M
is
si
ng
n
=
3
Su
sc
ep
ti
bi
lit
y
re
su
lt
s
ro
ut
in
el
y
re
po
rt
ed
fo
r
re
st
ri
ct
ed
an
ti
bi
ot
ic
s
Ye
s
n
=
67
49
.1
(3
5.
9,
68
.7
)
N
o
n
=
46
61
.1
(4
6.
5,
81
.9
)
<0
.0
1
M
is
si
ng
n
=
11
Su
sc
ep
ti
bi
lit
y
re
su
lt
s
re
po
rt
ed
fo
r
no
n-
fo
rm
ul
ar
y
an
ti
bi
ot
ic
s
w
he
n
or
ga
ni
sm
s
re
si
st
an
t
to
fo
rm
ul
ar
y
ag
en
ts
Ye
s
n
=
41
53
.2
(3
9.
1,
66
.1
)
N
o
n
=
76
57
.7
(4
0.
1,
71
.9
)
0.
44
M
is
si
ng
n
=
7
Pr
es
cr
ib
in
g
ad
vi
ce
w
as
av
ai
la
bl
e
ou
ts
id
e
no
rm
al
w
or
ki
ng
ho
ur
s
Ye
s
n
=
11
5
55
.9
(4
0.
9,
72
.2
)
N
o
n
=
7
33
.9
(1
6.
3,
45
.6
)
0.
01
M
is
si
ng
n
=
2
Cl
in
ic
al
m
ic
ro
bi
ol
og
is
t/
ID
sp
ec
ia
lis
t
di
d
da
ily
w
ar
d
ro
un
d
to
ad
vi
se
on
th
er
ap
y
Ye
s
n
=
95
55
.4
(4
0.
8,
71
.1
)
N
o
n
=
27
49
.4
(3
3.
9,
72
.2
)
0.
49
M
is
si
ng
n
=
2
*M
an
n
W
hi
tn
ey
U
te
st
.
78 F.M. MacKenzie et al.
pharmacists carried out daily ward rounds to advise
on therapy.
Thirty-three (19%) and 23 (14%) hospitals
operated a voluntary system of automatic stop
(‘auto-stop’) dates for prophylaxis and treatment
respectively. Only 14 (8%) hospitals operated
compulsory automatic stop dates on prophylaxis
and 10 (6%) for treatment. Computerised antibiotic
prescribing was available in only 25 (15%) hospitals.
Regional responses to these questions were too low
to test for differences.
Association between antibiotic use and key
laboratory practices
Hospitals that routinely reported susceptibility
results for restricted antibiotics had signiﬁcantly
lower median total antibiotic use in 2001 (Table 4;
49.1 vs. 61.1 DDDs/100 BD; p < 0.01). Hospitals
that provided prescribing advice outside normal
working hours had signiﬁcantly higher antibiotic use
compared to institutions that did not provide this
service (55.9 vs 33.9; p = 0.01), although hospital
numbers within this latter category were low
(Table 4). No statistically signiﬁcant associations
were found between any of the other key
laboratory practice variables and antibiotic use
(Table 4).
Association between antibiotic use and key
pharmacy practices
There was weak evidence to suggest some
association between antibiotic use and some of
the key pharmacy practices. In fact, antibiotic
use in hospitals providing pharmacy advice during
normal working hours was almost half that of those
hospitals that did not provide such advice (p = 0.04)
(Table 5).
Discussion
The aim of this study was to describe the
contribution made by European hospital-based
microbiology and pharmacy departments to antibi-
otic stewardship and to describe any associations
between either policy or practice and antibiotic
consumption. Being the ﬁrst European study of
its kind, it is a major contribution to current
knowledge. Whilst much is known about antibiotic
policies in some individual countries, our study is
the ﬁrst to explore these issues at a European level,
to compare differences and look for associations
with antibiotic use. The fact that there were higher
levels of antibiotic use in hospitals that did have
indicators of ‘good practice’ may indicate that
these are very active, acute care hospitals and/or
that these stewardship measures were instigated
in response to high consumption rather than being
the cause of it.
This study was conducted to gain insight into
the content of key areas of antibiotic policies
across Europe and establish any relationships
between policy content and antibiotic use. It was
not designed to assess the practice of antibiotic
stewardship over time, nor was it designed to
establish the relationship between cause and
effect or direction of effect.
There are many methodological strengths of the
ARPAC study, as well as accepted limitations and
these have been discussed elsewhere.8-10 Other
results from the ARPAC study found that antibiotic
resistance prevalence, antibiotic use and infection
control policies and practice all varied signiﬁcantly
with geographical region.6,8-10 We, however, found
that microbiology and pharmacy-led initiatives to
optimise antibiotic prescribing in the hospital did
not vary to any great extent across Europe.
A Cochrane review recently cited 66 published
studies which described interventions to improve
antibiotic prescribing in hospitals.11 In 22 of
these studies the relevant intervention was led by
pharmacists and in 17 by infection specialists. The
pharmacist-led interventions were predominantly
educational, such as reviewing patient charts and
recommending changes, and tended to measure
outcome only in terms of drug use rather than
microbial or clinical outcome. In contrast, the ma-
jority of interventions led by infection specialists
tended to be restrictive such as controlling access
to restricted agents. Of the 66 interventions, a
total of 29 were educational, 27 were restrictive,
seven were mixed and three structural. Two of
the three structural interventions instigated rapid
identiﬁcation and antibiotic susceptibility testing
and the third provided a pharmacokinetic service
for predicting aminoglycoside serum levels. One
of the restrictive and four of the educational
interventions were carried out by computer or
written feedback. The authors concluded that
restrictive interventions were more successful than
educational interventions, at least in the short
term, but there was little evidence for control
of resistance by these interventions. Indeed it
is possible that some of the interventions were
associated with poorer patient outcome. Much
more robust research is needed in this area,
particularly to assess the relationship between
interventions and relevant clinical outcomes.
In the meantime, repeated audits of antibiotic
prescribing12,13 and analysis of resistance data14
give great cause for concern about unnecessary
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and poor quality antibiotic prescribing and major
increases in resistance problems in European hos-
pitals. Our ﬁndings show that infection specialists
are trying to address this by providing frequent out-
of-hours services, clinical advice and ward rounds.
The activities of pharmacists however, leave room
for expansion outside normal working hours. We
found similar trends in related educational and
audit activities, which will be the subject of
another report.
The provision of continuous blood culture
monitoring to provide rapid results to guide therapy
has been shown to improve both the quality and
quantity of antibiotic use, as well as improved
patient outcome.15-17 The provision of antibiotic
susceptibility summary data at a local level is the
best way to inform local antibiotic policies for the
provision of empiric therapy, given the variation in
local susceptibility patterns. The limited reporting
of non-formulary and restricted agents seems
sensible as reporting of agents is often seen by
clinicians as a recommendation to treat with these
agents.18 Lastly, the frequent reporting of MIC
values is seen as important now that the value of
the MIC in deﬁning optimal antibiotic treatment in
critically ill patients is known.19
The ARPAC study found that relatively few
pharmacists carry out ward rounds. There may
be stafﬁng issues here but there are increasing
moves to create antibiotic/infectious-diseases
pharmacists similar to those who have practised
in the USA for many years.5 There is a new MSc in
Infection Management for Pharmacists organised by
Imperial College, London, UK and some countries
have funded development programmes, sometimes
in the context of multi-disciplinary teams.
A small number of hospitals encourage voluntary
auto-stop of prescriptions; even fewer enforce
compulsory auto-stop regimes. Data exist which
suggest this is a reasonable method of reducing
unnecessarily prolonged prescriptions20 but there
are concerns that it can be unsafe, leading to
premature cessation of therapy. Computerised pre-
scribing has many advocates although supportive
literature is limited.21 Computerised prescribing
was rarely practised in ARPAC hospitals, probably
due to lack of computer facilities. Computerisation
can improve both the quality of prescribing and
the ability to audit, and there is huge scope for
widespread implementation across Europe. It was,
however, associated with marginally signiﬁcant
increases in consumption in this study although
the low proportions of computerised prescribing
decreased the likelihood of detecting an effect.
In conclusion, there is ample scope to increase
support service activity in antibiotic stewardship
in European hospitals. In particular, the role of
pharmacists should be expanded as an integral part
of multidisciplinary antibiotic teams.
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